These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24250937)

  • 1. Inter-individual Variability of Coumarin 7-hydroxylation (CYP2A6 activity) in an Iranian Population.
    Hassanzadeh Khayyat M; Vahdati Mashhadian N; Eghbal S; Jalali N
    Iran J Basic Med Sci; 2013 Apr; 16(4):610-4. PubMed ID: 24250937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interindividual variability of coumarin 7-hydroxylation in a Turkish population.
    Iscan M; Rostami H; Iscan M; Güray T; Pelkonen O; Rautio A
    Eur J Clin Pharmacol; 1994; 47(4):315-8. PubMed ID: 7875181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers.
    Rautio A; Kraul H; Kojo A; Salmela E; Pelkonen O
    Pharmacogenetics; 1992 Oct; 2(5):227-33. PubMed ID: 1306122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of coumarin metabolism in Turkish population.
    Cok I; Aygün Kocabaş N; Cholerton S; Karakaya AE; Sardaş S
    Hum Exp Toxicol; 2001 Apr; 20(4):179-84. PubMed ID: 11393269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis A impairs the function of human hepatic CYP2A6 in vivo.
    Pasanen M; Rannala Z; Tooming A; Sotaniemi EA; Pelkonen O; Rautio A
    Toxicology; 1997 Dec; 123(3):177-84. PubMed ID: 9355936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consumption of watercress fails to alter coumarin metabolism in humans.
    Murphy SE; Johnson LM; Losey LM; Carmella SG; Hecht SS
    Drug Metab Dispos; 2001 Jun; 29(6):786-8. PubMed ID: 11353744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6.
    Hadidi H; Irshaid Y; Vågbø CB; Brunsvik A; Cholerton S; Zahlsen K; Idle JR
    Eur J Clin Pharmacol; 1998 Jul; 54(5):437-41. PubMed ID: 9754990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evaluation of coumarin and nicotine as probe drugs to predict the metabolic capacity of CYP2A6 due to genetic polymorphism in Thais.
    Peamkrasatam S; Sriwatanakul K; Kiyotani K; Fujieda M; Yamazaki H; Kamataki T; Yoovathaworn K
    Drug Metab Pharmacokinet; 2006 Dec; 21(6):475-84. PubMed ID: 17220563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coumarin 7-hydroxylation in long-term adherents of a strict uncooked vegan diet.
    Rauma AL; Rautio A; Pasanen M; Pelkonen O; Törrönen R; Mykkänen H
    Eur J Clin Pharmacol; 1996; 50(1-2):133-7. PubMed ID: 8739824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients.
    Sotaniemi EA; Rautio A; Bäckstrom M; Arvela P; Pelkonen O
    Br J Clin Pharmacol; 1995 Jan; 39(1):71-6. PubMed ID: 7756103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin.
    Hadidi H; Zahlsen K; Idle JR; Cholerton S
    Food Chem Toxicol; 1997 Sep; 35(9):903-7. PubMed ID: 9409631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation.
    Pearce R; Greenway D; Parkinson A
    Arch Biochem Biophys; 1992 Oct; 298(1):211-25. PubMed ID: 1381906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in coumarin 7-hydroxylase activity associated with genetic polymorphism of cytochrome P450 2A6 and the body status of iron stores in adult Thai males and females.
    Ujjin P; Satarug S; Vanavanitkun Y; Daigo S; Ariyoshi N; Yamazaki H; Reilly PE; Moore MR; Kamataki T
    Pharmacogenetics; 2002 Apr; 12(3):241-9. PubMed ID: 11927840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism.
    Oscarson M
    Drug Metab Dispos; 2001 Feb; 29(2):91-5. PubMed ID: 11159795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose disulfiram does not inhibit CYP2A6 activity.
    Kharasch ED; Hankins DC; Baxter PJ; Thummel KE
    Clin Pharmacol Ther; 1998 Jul; 64(1):39-45. PubMed ID: 9695717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.
    Kharasch ED; Hankins DC; Taraday JK
    Drug Metab Dispos; 2000 Jan; 28(1):28-33. PubMed ID: 10611136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6.
    von Weymarn LB; Murphy SE
    Xenobiotica; 2003 Jan; 33(1):73-81. PubMed ID: 12519695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single copy of variant CYP2A6 alleles does not confer susceptibility to liver dysfunction in patients treated with coumarin.
    Burian M; Freudenstein J; Tegtmeier M; Naser-Hijazi B; Henneicke-von Zepelin HH; Legrum W
    Int J Clin Pharmacol Ther; 2003 Apr; 41(4):141-7. PubMed ID: 12708602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemisinin and CYP2A6 activity in healthy subjects.
    Asimus S; Hai TN; Van Huong N; Ashton M
    Eur J Clin Pharmacol; 2008 Mar; 64(3):283-92. PubMed ID: 18064444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.